Non-invasive lung cancer diagnosis and prognosis based on multi-analyte liquid biopsy
Open Access
- 29 January 2021
- journal article
- letter
- Published by Springer Science and Business Media LLC in Molecular Cancer
- Vol. 20 (1), 1-7
- https://doi.org/10.1186/s12943-021-01323-9
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (No.82072566, No.81602001)
- peking university people's hospital research and development funds (RS2019-01)
- Shenzhen Engineering Laboratory for Innovative Molecular Diagnostics (DRC-SZ[2016]884)
This publication has 10 references indexed in Scilit:
- Feasibility of blood testing combined with PET-CT to screen for cancer and guide interventionScience, 2020
- Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNAAnnals of Oncology, 2020
- Integrating genomic features for non-invasive early lung cancer detectionNature, 2020
- High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variantsNature Medicine, 2019
- RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissuesScience, 2019
- Resectable lung lesions malignancy assessment and cancer detection by ultra-deep sequencing of targeted gene mutations in plasma cell-free DNAJournal of Medical Genetics, 2019
- Liquid biopsy in newly diagnosed patients with locoregional (I-IIIA) non-small cell lung cancerExpert Review of Molecular Diagnostics, 2019
- Detection and localization of surgically resectable cancers with a multi-analyte blood testScience, 2018
- Direct detection of early-stage cancers using circulating tumor DNAScience Translational Medicine, 2017
- Targeted sequencing reveals clonal genetic changes in the progression of early lung neoplasms and paired circulating DNANature Communications, 2015